With the bewildering amount of news about stem cells, how do we tell the difference between hype and hope? Although the words “hype” and “hope” only differ by one letter, sometimes it is hard to tell them apart in real life, but of course they are very different things. So how do we know when […]
Stem cell hype: distinguishing it from hope Read More »
I believe that stem cells may at some point allow people to live slightly longer, maybe a couple years on average. However, I think they have the potential to dramatically increase the quality of life during the time we are alive. My colleague Amy Adams over at the CIRM research blog had a great post
Portraying sci-fi about stem cells and aging as reality: quotes from Aubrey de Grey Read More »
What is ISSCR doing about unproven stem cell clinics? One of the greatest and most infuriating ironies of the stem cell-based regenerative medicine universe is that while the FDA strictly regulates the progress of therapy development by Advanced Cell Technology (ACT) and Geron and other legitimate companies, at the same time mysteriously the FDA essentially
ISSCR KO’d in round one versus unproven clinics: where’s the FDA? Read More »
How can I make money from stem cells? Someone recently asked me this question and more often I get asked “Which stem cell companies do YOU like as a stem cell scientist?” Just today an article went out that said that the global market for stem cell products will be $65 billion by 2015. That’s
How to make money from stem cells Read More »
What really happens to cells after they a stem cell transplant into a patient? Once these cells, which have spent weeks in a lab environment, are injected into a person, what happens next? This is arguably the most important question in the regenerative medicine field, but there are few answers. We are literally mostly in
Stem cells gone wild? What really happens after a transplant Read More »
What is the valley of death of science and biotech? For those of us conducting stem cell research, especially human stem cell research, I don’t have to tell you how expensive it is. Even just doing pre-clinical or basic science research costs a fortune. When you start talking about the kind of pre-clinical research specifically
The valley of death: stem cells, biotechs, and money Read More »
The best talk today was the keynote address by Dr. George Daley focused mostly on iPS cells. Dr. Daley is one of the world’s experts on iPS cells and pluripotent stem cells more generally. He covered many interesting elements of the iPS cell field including the genetic mutations that seem to occur during the reprogramming
Summary of George Daley talk on iPS cells today in Seattle Read More »
This past week was a wacky and wild one for the stem cell field. All kinds of crazy things happened all in one week. What does it all mean? Stem cells the new steroids for sports? Reports surface this week that NY Yankees pitcher Bartolo Colon, had received a non-FDA approved stem cell treatment for
A crazy week for stem cells: what the heck does it all mean? Read More »
Why invest in stem cells? Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of
Why invest in stem cells? Progress, Patients, and Patents Read More »
Six months ago, I published a Top 10 list of questions and predictions for the stem cell field. How did I do? A mixed bag. Below are the questions and predictions from October 2010 (in blue), along with an update as to how my predictions fared. 1) How will Geron’s Phase I Clinical Trial go?
Stem Cell Questions & Predictions: how did I do? Read More »